Diabetes
55:281-289,
2006
DOI: 10.2337/diabetes.55.02.06.db05-0963
© 2006 by the American Diabetes Association
Inhibition of p38MAPK Increases Adipogenesis From Embryonic to Adult Stages
Myriam Aouadi,
Kathiane Laurent,
Matthieu Prot,
Yannick Le Marchand-Brustel,
Bernard Binétruy, and
Frédéric Bost
From the Institut National de la Santé et de al Recherche Médicale (INSERM) U568, Nice, France; and Université de Nice Sophia Antipolis, Faculte de Médicine, Nice, France
Address correspondence and reprint requests to Frédéric Bost or Bernard Binétruy, Faculte de Medecine, INSERM U568, Avenue de Valombrose, Nice 06107, France. E-mail: bost{at}unice.fr or bernard.binetruy{at}medecine.univ-mrs.fr
Key Words: C/EBPß, CCAAT/enhancer-binding protein ß ERK, extracellular signal–regulated kinase JNK, c-Jun amino-terminal kinase MAPK, mitogen-activated protein kinase MEF, mouse embryonic fibroblast NFAT, nuclear factor of activated T-cell PPAR, peroxisome proliferator–activated receptor PPRE, PPAR responsive element PPRE-luc, PPRE-luciferase TZD, thiazolidinedione
Formation of new adipocytes from precursor cells contributes to adipose tissue expansion and obesity. In this study, we asked whether p38 mitogen-activated protein kinase (MAPK) pathway regulates normal and pathological adipogenesis. In both dietary and genetically (ob/ob) obese mice, adipose tissues displayed a marked decrease in p38MAPK activity compared with the same tissues from lean mice. Furthermore, p38MAPK activity was significantly higher in preadipocytes than in adipocytes, suggesting that p38MAPK activity decreases during adipocyte differentiation. In agreement with an inhibitory role of p38MAPK in this process, we found that in vitro inhibition of p38MAPK, with the specific inhibitor PD169316, increased the expression of adipocyte markers in several cellular models, from embryonic to adult stages. Importantly, the expression of adipocyte markers was higher in p38MAPK knockout cells than in their wild-type counterparts. Phosphorylation of C/EBPß, which enhances its transcriptional activity, is increased after p38MAPK inhibition. Finally, either inhibition or disruption of p38MAPK increased peroxisome proliferator–activated receptor (PPAR) expression and transactivation. Rescue of p38MAPK in knockout cells reduced PPAR activity to the low basal level of wild-type cells. We demonstrate here, by using multipronged approaches involving p38 chemical inhibitor and p38MAPK knockout cells, that p38MAPK plays a negative role in adipogenesis via inhibition of C/EBPß and PPAR transcriptional activities.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Demars, J. Riquet, M.-P. Sanchez, Y. Billon, J.-F. Hocquette, B. Lebret, N. Iannuccelli, J.-P. Bidanel, D. Milan, and F. Gondret
Metabolic and histochemical characteristics of fat and muscle tissues in homozygous or heterozygous pigs for the body composition QTL located on chromosome 7
Physiol Genomics,
August 20, 2007;
30(3):
232 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Tesz, A. Guilherme, K. V. P. Guntur, A. C. Hubbard, X. Tang, A. Chawla, and M. P. Czech
Tumor Necrosis Factor {alpha} (TNF{alpha}) Stimulates Map4k4 Expression through TNF{alpha} Receptor 1 Signaling to c-Jun and Activating Transcription Factor 2
J. Biol. Chem.,
July 6, 2007;
282(27):
19302 - 19312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Diaz-Delfin, M. Morales, and C. Caelles
Hypoglycemic Action of Thiazolidinediones/Peroxisome Proliferator-Activated Receptor {gamma} by Inhibition of the c-Jun NH2-Terminal Kinase Pathway
Diabetes,
July 1, 2007;
56(7):
1865 - 1871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Binetruy, L. Heasley, F. Bost, L. Caron, and M. Aouadi
Concise Review: Regulation of Embryonic Stem Cell Lineage Commitment by Mitogen-Activated Protein Kinases
Stem Cells,
May 1, 2007;
25(5):
1090 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Prot, L. Heripret, N. Cardot-Leccia, C. Perrin, M. Aouadi, T. Lavrut, R. Garraffo, P. Dellamonica, J. Durant, Y. Le Marchand-Brustel, et al.
Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice
Antimicrob. Agents Chemother.,
December 1, 2006;
50(12):
3998 - 4004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Faustman, S. D. Tran, S. Kodama, B. M. Lodde, I. Szalayova, S. Key, Z. E. Toth, and E. Mezey
Comment on Papers by Chong et al., Nishio et al., and Suri et al. on Diabetes Reversal in NOD Mice
Science,
November 24, 2006;
314(5803):
1243a - 1243a.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|